Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 236085, 7 pages
http://dx.doi.org/10.1155/2013/236085
Research Article

Acylated and Desacylated Ghrelin, Preptin, Leptin, and Nesfatin-1 Peptide Changes Related to the Body Mass Index

1Department of Endocrinology and Metabolism, Firat University Hospital, 23119 Elazig, Turkey
2Department of Medical Biochemistry and Clinical Biochemistry, Firat Hormones Research Group, Firat University Hospital, 23119 Elazig, Turkey
3Department of Histology and Embryology, Medical School, Erzincan University, 24100 Erzincan, Turkey
4Atatürk Vocational School of Health Science, Kafkas University, 36040 Kars, Turkey
5Department of Nutrition and Dietetic, Bitlis Eren University, 13000 Bitlis, Turkey

Received 2 August 2013; Revised 17 October 2013; Accepted 5 November 2013

Academic Editor: Daniela Jezova

Copyright © 2013 Yusuf Ozkan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, “Ghrelin is a growth-hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Aydın, Y. Özkan, E. Çaylak, and S. Aydın, “Ghrelin and its biochemical functions,” Journal of Medical Sciences, vol. 26, no. 3, pp. 272–283, 2006. View at Google Scholar
  3. K. Majchrzak, K. Szyszko, K. M. Pawłowski, T. Motyl, and M. Król, “A role of ghrelin in cancerogenesis,” Polish Journal of Veterinary Sciences, vol. 15, no. 1, pp. 189–197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Aydın, “Ghrelin Hormonunun Keşfi, Araştırmaları ve Klinik Uygulamaları,” Turkish Journal of Biochemistry, vol. 32, no. 2, pp. 76–89, 2007. View at Google Scholar
  5. T. Inhoff, B. Wiedenmann, B. F. Klapp, H. Mönnikes, and P. Kobelt, “Is desacyl ghrelin a modulator of food intake?” Peptides, vol. 30, no. 5, pp. 991–994, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, H. Sugihara, and S. Oikawa, “Regulation of the Ghrelin gene: growth hormone-releasing hormone upregulates Ghrelin mRNA in the pituitary,” Endocrinology, vol. 142, no. 9, pp. 4154–4157, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Buchanan, A. R. J. Phillips, and G. J. S. Cooper, “Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet β-cells and enhances insulin secretion,” Biochemical Journal, vol. 360, part 2, pp. 431–439, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Celik, N. Celik, S. Hascalik, I. Sahin, S. Aydin, and E. Ozerol, “An appraisal of serum preptin levels in PCOS,” Fertility and Sterility, vol. 95, no. 1, pp. 314–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Hoog, W. Hu, S. M. Abdel-Halim, S. Falkmer, L. Qing, and L. Grimelius, “Ultrastructural localization of insulin-like growth factor-2 (IGF-2) to the secretory granules of insulin cells: a study in normal and diabetic (GK) rats,” Ultrastructural Pathology, vol. 21, no. 5, pp. 457–466, 1997. View at Google Scholar · View at Scopus
  10. D. Canoy and I. Buchan, “Challenges in obesity epidemiology,” Obesity Reviews, vol. 8, supplement 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Su, J. Zhang, Y. Tang, F. Bi, and J. Liu, “The novel function of nesfatin-1: anti-hyperglycemia,” Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 1039–1042, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Deniz, B. Gurates, S. Aydin et al., “Nesfatin-1 and other hormone alterations in polycystic ovary syndrome,” Endocrine, vol. 42, no. 3, pp. 694–699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Aydin, “Multi-functional peptide hormone NUCB2/nesfatin-1,” Endocrine, vol. 44, no. 2, pp. 312–325, 2013. View at Google Scholar
  14. S. Oh-I, H. Shimizu, T. Satoh et al., “Identification of nesfatin-1 as a satiety molecule in the hypothalamus,” Nature, vol. 443, no. 7112, pp. 709–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Hims-Hagen, “Physiological roles of the leptin endocrine system: differences between mice and humans,” Critical Reviews in Clinical Laboratory Sciences, vol. 36, no. 6, pp. 575–655, 1999. View at Google Scholar · View at Scopus
  16. M. K. Sinha, I. Opentanova, J. P. Ohannesian et al., “Evidence of free and bound leptin in human circulation: studies in lean and obese subjects and during short-term fasting,” The Journal of Clinical Investigation, vol. 98, no. 6, pp. 1277–1282, 1996. View at Google Scholar · View at Scopus
  17. R. S. Ahima, D. Prabakaran, and J. S. Flier, “Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function,” The Journal of Clinical Investigation, vol. 101, no. 5, pp. 1020–1027, 1998. View at Google Scholar · View at Scopus
  18. M. G. McConway, D. Johnson, A. Kelly, D. Griffin, J. Smith, and A. M. Wallace, “Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans,” Annals of Clinical Biochemistry, vol. 37, part 5, pp. 717–723, 2000. View at Google Scholar · View at Scopus
  19. R. S. Ahima and J. S. Flier, “Leptin,” Annual Review of Physiology, vol. 62, pp. 413–437, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. C. S. Mantzoros, “Leptin in relation to the lipodystrophy-associated metabolic syndrome,” Diabetes and Metabolism Journal, vol. 36, no. 3, pp. 181–189, 2012. View at Google Scholar
  21. H. Hosoda, K. Doi, N. Nagaya et al., “Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples,” Clinical Chemistry, vol. 50, no. 6, pp. 1077–1080, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. K. M. Flegal, M. D. Carroll, C. L. Ogden, and L. R. Curtin, “Prevalence and trends in obesity among US adults, 1999–2008,” Journal of the American Medical Association, vol. 303, no. 3, pp. 235–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Onat, D. Dursunoglu, G. Kahraman et al., “Türk erişkinlerinde ölüm ve koroner olaylar: TEKHARF çalışması kohortunun 5 yıllık takibi,” Archives of the Turkish Society of Cardiology, vol. 24, no. 1, pp. 8–15, 1996. View at Google Scholar
  24. H. Hatemi, N. Turan, N. Arık, and V. Yumruk, “Türkiye Obezite ve Hipertansiyon Taraması Sonuçları (TOHTA),” Endokrinolojide Yönelişler Dergisi, vol. 11, pp. 1–15, 2002. View at Google Scholar
  25. B. Popkin, C. Monteiro, and B. Swinburn, “Overview: bellagio conference on program and policy options for preventing obesity in the low- and middle-income countries,” Obesity Reviews, vol. 14, supplement 2, pp. 1–8, 2013. View at Google Scholar
  26. E. Bruckert, P. Giral, V. Ratziu et al., “A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients,” Metabolism, vol. 51, no. 8, pp. 1071–1076, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Clark, F. L. Brancati, and A. M. Diehl, “The prevalence and etiology of elevated aminotransferase levels in the United States,” American Journal of Gastroenterology, vol. 98, no. 5, pp. 960–967, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. LeMura and M. T. Maziekas, “Factors that alter body fat, body mass, and fat-free mass in pediatric obesity,” Medicine and Science in Sports and Exercise, vol. 34, no. 3, pp. 487–496, 2002. View at Google Scholar · View at Scopus
  29. M. Kojima and K. Kangawa, “Ghrelin: structure and function,” Physiological Reviews, vol. 85, no. 2, pp. 495–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. I. Van der Lely, M. Tschop, and M. L. Heiman, “Biological, physiological, pathophysiological and pharmacological aspects of ghrelin,” Endocrine Reviews, vol. 25, no. 3, pp. 426–457, 2004. View at Google Scholar
  31. J. M. Lyznicki, D. C. Young, J. A. Riggs, and R. M. Davis, “Obesity: assessment and management in primary care,” American Family Physician, vol. 63, no. 11, pp. 2185–2196, 2001. View at Google Scholar · View at Scopus
  32. M. Gröschl, H. G. Topf, J. Bohlender et al., “Identification of ghrelin in human saliva: production by the salivary glands and potential role in proliferation of oral keratinocytes,” Clinical Chemistry, vol. 51, no. 6, pp. 997–1006, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Sahin, S. Aydin, Y. Ozkan et al., “Diet-induced obesity suppresses ghrelin in rat gastrointestinal tract and serum,” Molecular and Cellular Biochemistry, vol. 355, no. 1-2, pp. 299–308, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Broglio, C. Gottero, F. Prodam et al., “Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans,” Clinical Endocrinology, vol. 61, no. 4, pp. 503–509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Tschöp, C. Weyer, P. A. Tataranni, V. Devanarayan, E. Ravussin, and M. L. Heiman, “Circulating ghrelin levels are decreased in human obesity,” Diabetes, vol. 50, no. 4, pp. 707–709, 2001. View at Google Scholar · View at Scopus
  36. G. Murdolo, P. Lucidi, C. Di Loreto et al., “Insulin is required for prandial ghrelin suppression in humans,” Diabetes, vol. 52, no. 12, pp. 2923–2927, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Yang, L. Li, W. Chen, H. Liu, G. Boden, and K. Li, “Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects,” Annals of Medicine, vol. 41, no. 1, pp. 52–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Ramanjaneya, J. Chen, J. E. Brown et al., “Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity,” Endocrinology, vol. 151, no. 7, pp. 3169–3180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Tsuchiya, H. Shimizu, M. Yamada et al., “Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males,” Clinical Endocrinology, vol. 73, no. 4, pp. 484–490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Stengel, M. Goebel, L. Wang et al., “Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor,” Endocrinology, vol. 150, no. 11, pp. 4911–4919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Nakahara, R. Okame, T. Katayama, M. Miyazato, K. Kangawa, and N. Murakami, “Nutritional and environmental factors affecting plasma ghrelin and leptin levels in rats,” The Journal of Endocrinology, vol. 207, no. 1, pp. 95–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Doucet, S. St-Pierre, N. Alméras et al., “Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 11, pp. 4231–4237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Hyatt, E. A. Butt, H. Budge, T. Stephenson, and M. E. Symonds, “Effects of maternal cold exposure and nutrient restriction on the ghrelin receptor, the GH-IGF axis, and metabolic regulation in the postnatal ovine liver,” Reproduction, vol. 135, no. 5, pp. 723–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. K. S. Bell-Anderson and J. M. Bryson, “Leptin as a potential treatment for obesity: progress to date,” Treatments in Endocrinology, vol. 3, no. 1, pp. 11–18, 2004. View at Publisher · View at Google Scholar · View at Scopus